Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Other Gross PP&E Adjustments (2020 - 2025)

Bioventus' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at $60.4 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 1.66% year-over-year to $60.4 million; the TTM value through Dec 2025 reached $60.4 million, down 1.66%, while the annual FY2025 figure was $60.4 million, 1.66% down from the prior year.
  • Other Gross PP&E Adjustments reached $60.4 million in Q4 2025 per BVS's latest filing, up from -$11.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $62.8 million in Q4 2023 to a low of -$38.1 million in Q2 2023.
  • Average Other Gross PP&E Adjustments over 5 years is $5.6 million, with a median of -$12.9 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 348.61% in 2024, then tumbled 128.29% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $28.9 million in 2021, then skyrocketed by 43.81% to $41.6 million in 2022, then surged by 51.18% to $62.8 million in 2023, then fell by 2.18% to $61.5 million in 2024, then decreased by 1.66% to $60.4 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Other Gross PP&E Adjustments are $60.4 million (Q4 2025), -$11.6 million (Q3 2025), and -$12.0 million (Q2 2025).